We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




FFDM Breast Cancer Screening Combined with 3D ABUS to Reduce the Incidence of Interval Cancer

By HospiMedica International staff writers
Posted on 27 Jun 2016
The results of a Swedish study have shown that the addition of 3D Automated Breast Ultrasound (ABUS) to a Full-Field Digital Mammography (FFDM) screening program could reduce the likelihood of interval cancers.

Interval breast cancer cases are those cancers that are found within one year after a women undergoes a mammographic screening that has resulted in normal findings.

The researchers from the Unilabs Mammography Capio St Goran Hospital (Stockholm, Sweden) enrolled 1,675 asymptomatic women who took part in a service-screening program between November 2010 and February 2012. More...
The women underwent a visual mammographic assessment and had more than 50% density in their breasts. As a next step, the researchers acquired and reviewed bilateral ABUS scans together with double-read two-view FFDM screening.

The study was published as a poster in the European Society of Radiology’s annual European Congress of Radiology (ECR 2016) in Vienna, Austria.

By combined mammography service screening using bilateral ABUS scans with double-read two-view FFDM, the researchers were able to identify five women with invasive ductal estrogen and progesterone-positive interval cancers. All these women presented with a palpable breast lump. Three of the women were aged between 40 and 49.

The researchers concluded that the addition of bilateral ABUS scanning to a standard mammography-screening program could be useful for bringing down the number of interval cancers, but that further research was necessary.

Related Links:
Unilabs Mammography Capio St Goran Hospital


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Patient Monitoring System
AlarmSense
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.